These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22424435)

  • 41. Is it SLE?
    Maddison PJ
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):167-80. PubMed ID: 12041947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
    Ng KP; Manson JJ; Rahman A; Isenberg DA
    Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Customising an antibody leukocyte capture microarray for systemic lupus erythematosus: beyond biomarker discovery.
    Ho JW; Lin MW; Braet F; Su YY; Adelstein S; dos Remedios CG
    Proteomics Clin Appl; 2010 Feb; 4(2):179-89. PubMed ID: 21137042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
    Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
    Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic lupus erythematosus: clinical presentations.
    Smith PP; Gordon C
    Autoimmun Rev; 2010 Nov; 10(1):43-5. PubMed ID: 20850569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. One year in review 2016: systemic lupus erythematosus.
    Adinolfi A; Valentini E; Calabresi E; Tesei G; Signorini V; Barsotti S; Tani C
    Clin Exp Rheumatol; 2016; 34(4):569-74. PubMed ID: 27463977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The lupus biomarker odyssey: one experience.
    Ahearn JM; Manzi S; Liu CC
    Methods Mol Biol; 2014; 1134():17-35. PubMed ID: 24497351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in the diagnosis and classification of systemic lupus erythematosus.
    Larosa M; Iaccarino L; Gatto M; Punzi L; Doria A
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1309-1320. PubMed ID: 27362864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell-bound complement activation products as lupus biomarkers: diagnosis, monitoring and stratification.
    Ahearn JM; Liu CC; Manzi S
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1133-1142. PubMed ID: 29025354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One year in review 2018: systemic lupus erythematosus.
    Di Battista M; Marcucci E; Elefante E; Tripoli A; Governato G; Zucchi D; Tani C; Alunno A
    Clin Exp Rheumatol; 2018; 36(5):763-777. PubMed ID: 30272543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different end-points to assess effects in systemic lupus erythematosus patients exposed to pesticide mixtures.
    Simoniello MF; Contini L; Benavente E; Mastandrea C; Roverano S; Paira S
    Toxicology; 2017 Feb; 376():23-29. PubMed ID: 27497885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus.
    Yu H; Nagafuchi Y; Fujio K
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.
    Pejchinovski M; Siwy J; Mullen W; Mischak H; Petri MA; Burkly LC; Wei R
    Lupus; 2018 Jan; 27(1):6-16. PubMed ID: 28474961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.
    Choi MY; Barber MR; Barber CE; Clarke AE; Fritzler MJ
    Lupus; 2016 Jul; 25(8):838-49. PubMed ID: 27252260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical and early systemic lupus erythematosus.
    Gatto M; Saccon F; Zen M; Iaccarino L; Doria A
    Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101422. PubMed ID: 31810542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meta-analysis as a diagnostic tool for predicting disease onset and/or activity in systemic lupus erythematosus.
    Cottrell I; Khan A; Maqsood S; Thornes J; Eggleton P
    Methods Mol Biol; 2014; 1134():249-59. PubMed ID: 24497368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic criteria for systemic lupus erythematosus: has the time come?
    Bertsias GK; Pamfil C; Fanouriakis A; Boumpas DT
    Nat Rev Rheumatol; 2013 Nov; 9(11):687-94. PubMed ID: 23838616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinguishing infections vs flares in patients with systemic lupus erythematosus.
    Ospina FE; Echeverri A; Zambrano D; Suso JP; Martínez-Blanco J; Cañas CA; Tobón GJ
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i46-i54. PubMed ID: 27744359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic review.
    Nicolaou O; Kousios A; Hadjisavvas A; Lauwerys B; Sokratous K; Kyriacou K
    J Cell Mol Med; 2017 May; 21(5):993-1012. PubMed ID: 27878954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.